Suppliers / Rivopharm

Rivopharm

Switzerland 167 employees Updated 9 July 2026

Rivopharm is a finished-dose manufacturer based in Switzerland. It appears in 45 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with MPA (SE), AIFA (IT) and SWISSMEDIC (CH). Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 23 June 2023 as NAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
45
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 23 June 2023 NAI US FDA
  • 18 January 2019 VAI US FDA
  • 30 October 2015 VAI US FDA
  • 3 April 2014 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Manno, United Arab Emirates Not on file
MANNO, Switzerland Not on file
Switzerland, Switzerland 3005884589
Manno, Switzerland Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
MPA (SE) 23 None
AIFA (IT) 8 None
SWISSMEDIC (CH) 7 None
BOMRA (BW) 3 None
EDE (AE) 2 None
UZPHARM (UZ) 1 None
EMA None 2
US FDA None 1

Questions about Rivopharm

Does Rivopharm hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Rivopharm. It does have 45 filings with 7 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Rivopharm FDA-registered?
One site operated by Rivopharm carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Rivopharm's last inspection go?
The most recent inspection on record closed on 23 June 2023 as NAI (No Action Indicated: nothing objectionable was found). 4 inspections are on file.
Where does Rivopharm manufacture?
4 registered sites are on record, in United Arab Emirates and Switzerland (Manno, Manno and Switzerland among others). Every site is listed on this page with the register it came from.
Which regulators recognise Rivopharm's GMP?
Current GMP certificates are on record from EMA and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Rivopharm comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 23 June 2023.

Comparable suppliers

Acino Pharma also in Switzerland Alpex Pharma also in Switzerland Baccinex also in Switzerland Bracco Suisse also in Switzerland Drossapharm also in Switzerland

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates